Portfolio
•
May 28th, 2025

Why we invested in Koios Care

Turning everyday smartphones and smartwatches into objective, real-world measures of how Parkinson's affects daily life.

Parkinson's is the fastest-growing neurological disorder in the world. Yet for most patients, the disease is assessed during a few clinic visits a year, based on a short examination and whatever the patient can remember. Symptoms can swing from hour to hour, so neurologists adjust medication with only a partial picture, and pharmaceutical companies developing new therapies lack objective, real-world evidence of whether those therapies improve daily life.

Koios Care's platform, Parkiwatch, runs passively on devices people already own. It collects data from ordinary smartphones and smartwatches and uses AI to turn it into digital biomarkers of disease progression and health-related quality of life. Patients get a clearer view of their condition, neurologists get continuous, objective data between visits, and pharma gets a tool to measure how treatments perform outside the clinic. The approach is device-agnostic and inexpensive to deploy, and it is built to extend to other neurodegenerative conditions.

The company is backed by clinical partners including CHU de Liège and already has clinical evidence from a multi-centre European study. We like the dual model: a clinical tool that improves care today, and a real-world data engine that can speed up drug development tomorrow.

Above all, we invested in the people. Konstantinos Kyritsis and Dimitris Iakovakis did their research at Aristotle University of Thessaloniki, working on EU-funded projects such as i-PROGNOSIS and on detecting Parkinson's symptoms from smartphones and smartwatches in everyday life, years before they founded Koios Care. They understand both the science of digital biomarkers and how neurologists actually work, and as a Belgian-Greek team they are exactly the kind of European talent bridge we want to build. We believed they were the right people to turn years of research into a tool patients and doctors use every day.